Genertec Universal Medical Group Company Limited
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the People's Republic of China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; accounts receivable factoring; operating leases; and advisory services. Its… Read more
Market Cap & Net Worth: Genertec Universal Medical Group Company Limited (5UM)
Genertec Universal Medical Group Company Limited (F:5UM) has a market capitalization of $1.32 Billion (€1.29 Billion) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #9107 globally and #982 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genertec Universal Medical Group Company Limited's stock price €0.64 by its total outstanding shares 2014204924 (2.01 Billion).
Genertec Universal Medical Group Company Limited Market Cap History: 2015 to 2026
Genertec Universal Medical Group Company Limited's market capitalization history from 2015 to 2026. Data shows growth from $90.97 Million to $1.32 Billion (29.50% CAGR).
Genertec Universal Medical Group Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genertec Universal Medical Group Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
Genertec Universal Medical Group Company Limited's market cap is 0.09 times its annual revenue
1.82x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.57x
Genertec Universal Medical Group Company Limited's market cap is 0.57 times its annual earnings
0.83x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $127.77 Million | $2.70 Billion | $872.31 Million | 0.05x | 0.15x |
| 2017 | $168.71 Million | $3.42 Billion | $1.15 Billion | 0.05x | 0.15x |
| 2018 | $202.82 Million | $4.30 Billion | $1.35 Billion | 0.05x | 0.15x |
| 2019 | $353.55 Million | $6.82 Billion | $1.59 Billion | 0.05x | 0.22x |
| 2020 | $725.49 Million | $8.52 Billion | $1.75 Billion | 0.09x | 0.42x |
| 2021 | $1.24 Billion | $9.91 Billion | $1.95 Billion | 0.13x | 0.64x |
| 2022 | $1.14 Billion | $11.91 Billion | $1.96 Billion | 0.10x | 0.58x |
| 2023 | $1.03 Billion | $13.65 Billion | $2.11 Billion | 0.08x | 0.49x |
| 2024 | $1.19 Billion | $13.66 Billion | $2.10 Billion | 0.09x | 0.57x |
Competitor Companies of 5UM by Market Capitalization
Companies near Genertec Universal Medical Group Company Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Genertec Universal Medical Group Company Limited by market ranking:
- Visa Inc. Class A (NYSE:V): Ranked #20 globally with a market cap of $520.24 Billion USD.
- Mastercard Inc (NYSE:MA): Ranked #24 globally with a market cap of $434.78 Billion USD.
- American Express Company (NYSE:AXP): Ranked #106 globally with a market cap of $157.06 Billion USD.
- Capital One Financial Corporation (NYSE:COF): Ranked #175 globally with a market cap of $109.74 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #20 | Visa Inc. Class A | NYSE:V | $520.24 Billion | $299.02 |
| #24 | Mastercard Inc | NYSE:MA | $434.78 Billion | $488.47 |
| #106 | American Express Company | NYSE:AXP | $157.06 Billion | $294.39 |
| #175 | Capital One Financial Corporation | NYSE:COF | $109.74 Billion | $180.14 |
Genertec Universal Medical Group Company Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Genertec Universal Medical Group Company Limited's market cap moved from $90.97 Million to $ 1.32 Billion, with a yearly change of 29.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.32 Billion | +2.40% |
| 2025 | €1.29 Billion | +8.70% |
| 2024 | €1.19 Billion | +15.00% |
| 2023 | €1.03 Billion | -9.09% |
| 2022 | €1.14 Billion | -8.33% |
| 2021 | €1.24 Billion | +70.99% |
| 2020 | €725.49 Million | +105.20% |
| 2019 | €353.55 Million | +74.31% |
| 2018 | €202.82 Million | +20.22% |
| 2017 | €168.71 Million | +32.04% |
| 2016 | €127.77 Million | +40.45% |
| 2015 | €90.97 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Genertec Universal Medical Group Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.32 Billion USD |
| MoneyControl | $1.32 Billion USD |
| MarketWatch | $1.32 Billion USD |
| marketcap.company | $1.32 Billion USD |
| Reuters | $1.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.